Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

A vote taken by the sound of applause rang out during an early morning session at (AAO) 2026 annual meeting, where 2 experts discussed the pros and cons of using complement inhibitors to treat ...

The Bimatoprost Drug Pad-IOL (BIM-IOL) System, developed by SpyGlass Pharma, uses 2 drug-eluting pads attached to the lens to ...

CAR T-cell therapy must be treated as a complete "vein-to-vein" episode, with community practices needing to take control of cases for a period of time. Experts tackled CAR T access, trial equity, and ...

COA's Nicolas Ferreyros discusses real-world survival data for community oncology, health system consolidation, and barriers to CAR T-cell access. OneOncology's Edward "Ted" Arrowsmith, MD, MPH, ...

In the pivotal BRUNELLO trial, both doses of remigromig, a Wnt pathway agonist, were noninferior to ranibizumab for diabetic ...

A session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help ...

Access to emergency eye care remains a public health challenge, with gaps that affect patients and communities across the ...

Artificial intelligence (AI) could help close gaps in eye care for underserved communities, but only if the tools reach the ...

Cepheid's Connie Savor, MD, MBA, explains where its 13-pathogen respiratory panel fits in diagnostic stewardship and antibiotic decisions.

The opening session of AAO 2026 featured a keynote speech discussing how artificial intelligence (AI) will play a part in ...

Adults with colorectal cancer (CRC) in states that expanded Medicaid under the Affordable Care Act (ACA) had lower mortality ...